Developer docs
API playgroundTry for free, no card

Search company profiles

iThera Medical

Full company profile

uuid00029z7

Namestring
iThera Medical
Legal namestring
iThera Medical GmbH
Websiteurl
ithera-medical.com
Company typeenum
Private
Founded yearint
2010
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMünchen, Germany
HQ citystring
München
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
optoacoustic imaging, photoacoustic tomography, multispectral optoacoustic tomography, medical diagnostic imaging, non-invasive clinical diagnostics
Industry3 codes
1Mammography & Breast Imaging Systems
CodeHLAHABAFPrimaryYes
2Ultrasound & Echography Systems
CodeHLAHABADPrimaryNo
3Oncology Diagnostics (tumor profiling, MRD, liquid biopsy)
CodeHLAAALAEPrimaryNo
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Analytical Laboratory Instrument Manufacturing334516
  • Scientific Research and Development Services5417
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
  • Laboratory Analytical Instruments3826
Product category
Medical Imaging Equipment
Revenue model1 record
1Medical Device Sales (Planned)
TypeHardware Sales
Description

iThera Medical plans to commercialize clinical MSOT devices for diagnostic imaging. The company is developing a clinical MSOT device and seeking regulatory approvals in Europe and the US, indicating a future hardware/device revenue model.

finsmes.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

iThera Medical develops proprietary Multispectral Optoacoustic Tomography (MSOT) technology that combines optical excitation with ultrasound detection to deliver non-invasive, high-resolution diagnostic imaging. The company is translating its MSOT platform from research into clinical applications for detecting disease biomarkers related to inflammation, fibrosis, and cancer, and is developing a clinical MSOT device targeting regulatory approvals in Europe and the United States.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Non-invasive, radiation-free diagnostic imaging alternative to traditional mammography
Product overview1 text field

iThera Medical is a Munich-based medical device company that develops Multispectral Optoacoustic Tomography (MSOT) technology for clinical diagnostics. The company focuses on optoacoustic imaging systems designed to detect disease biomarkers related to inflammation, fibrosis, and cancer. Their technology translates MSOT from research settings into routine clinical use, with plans to develop clinical MSOT devices and obtain regulatory approvals in Europe and the US.

Product and service2 records
1MSOT (Multispectral Optoacoustic Tomography) Technology
CategoryMedical Imaging Technology
Description

Proprietary optoacoustic imaging technology that enables non-invasive visualization and quantification of functional, chemical and morphological tissue parameters by detecting disease biomarkers related to inflammation, fibrosis, and cancer through light absorption and ultrasound detection.

2Clinical MSOT Device (in development)
CategoryMedical Diagnostic Imaging Device
Description

A clinical-grade MSOT imaging device intended for hospital and clinical use, designed to detect tumor vascularization through hemoglobin concentration measurements and translate optoacoustic imaging into routine clinical diagnostics.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Seno Medical Instruments
TypeDirect peer
Description

Seno Medical develops the Imagio optoacoustic breast imaging system, the most direct US-based competitor to iThera's MSOT breast imaging application. Both target radiation-free, functional imaging of breast tumors using optoacoustic/photoacoustic principles.

2FUJIFILM VisualSonics
TypeDirect peer
Description

VisualSonics (owned by FUJIFILM) offers Vevo preclinical photoacoustic and high-frequency ultrasound imaging systems. It is the leading commercial supplier of optoacoustic imaging to the preclinical research market that iThera also serves with its MSOT technology.

3ENDRA Life Sciences
TypeDirect peer
Description

ENDRA develops the TAEUS thermoacoustic/photoacoustic platform for tissue characterization, including fatty liver disease and other clinical applications. It overlaps directly with iThera on photoacoustic imaging modality and clinical translation strategy.

4TomoWave Laboratories
TypeDirect peer
Description

TomoWave develops preclinical and research-grade optoacoustic/photoacoustic imaging systems, including the LOIS-3D small-animal imager. It is one of the closest technical peers to iThera in the multispectral optoacoustic tomography category.

5PhotoSound Technologies
TypeEmerging player
Description

PhotoSound Technologies supplies optoacoustic imaging subsystems, probes, and components used in preclinical and clinical research. It overlaps with iThera as a supplier/adjacent technology provider in the optoacoustic ecosystem.

6Hologic
TypeBroad incumbent
Description

Hologic is the dominant supplier of mammography and breast biopsy systems (e.g., 3Dimensions, Genius AI). As the incumbent in breast imaging, it is the most relevant established competitor iThera's MSOT breast application must displace or complement.

7Siemens Healthineers
TypeBroad incumbent
Description

Siemens Healthineers offers a broad portfolio of imaging modalities (MRI, CT, ultrasound, mammography) with global sales, clinical evidence, and reimbursement infrastructure. It is the type of incumbent iThera would compete with or partner alongside in the clinical imaging market.

8GE HealthCare
TypeBroad incumbent
Description

GE HealthCare is a global leader in diagnostic imaging including mammography, ultrasound, and molecular imaging. It represents both a potential competitor and a strategic channel partner for clinical optoacoustic imaging adoption.

9Canon Medical Systems
TypeBroad incumbent
Description

Canon Medical Systems offers a full suite of diagnostic imaging equipment including ultrasound, CT, MRI and mammography. Its breadth and installed-base reach are comparable to other large incumbents that could integrate or compete with optoacoustic imaging.

10Philips Healthcare
TypeBroad incumbent
Description

Philips Healthcare provides diagnostic imaging, ultrasound, and image-guided therapy solutions globally. Like other broad incumbents, it sets the competitive benchmark iThera's MSOT must meet on workflow integration, evidence, and reimbursement.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks2 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors12 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

iThera Medical

Medical Imaging Equipmentithera-medical.com

iThera Medical firmographics

Firmographics
Name
iThera Medical
Legal name
iThera Medical GmbH
Website
https://ithera-medical.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

iThera Medical industry classification

Industry
Product category
Medical Imaging Equipment
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Analytical Laboratory Instrument Manufacturing (334516), Scientific Research and Development Services (5417)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), Laboratory Analytical Instruments (3826)
akta.pro primary industry
Mammography & Breast Imaging Systems (HLAHABAF)
akta.pro secondary industries
Ultrasound & Echography Systems (HLAHABAD), Oncology Diagnostics (tumor profiling, MRD, liquid biopsy) (HLAAALAE)

Keywords

  • Optoacoustic imaging
  • Photoacoustic tomography
  • Multispectral optoacoustic tomography
  • Medical diagnostic imaging
  • Non-invasive clinical diagnostics

Where iThera Medical is headquartered

Location

Headquarters

HQ city
München
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

iThera Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Medical Device Sales (Planned): iThera Medical plans to commercialize clinical MSOT devices for diagnostic imaging. The company is developing a clinical MSOT device and seeking regulatory approvals in Europe and the US, indicating a future hardware/device revenue model.

Distribution channels1 record

Marketing channels3 records

iThera Medical product offering

Product offering

Core offering

iThera Medical develops proprietary Multispectral Optoacoustic Tomography (MSOT) technology that combines optical excitation with ultrasound detection to deliver non-invasive, high-resolution diagnostic imaging. The company is translating its MSOT platform from research into clinical applications for detecting disease biomarkers related to inflammation, fibrosis, and cancer, and is developing a clinical MSOT device targeting regulatory approvals in Europe and the United States.

Product overview

iThera Medical is a Munich-based medical device company that develops Multispectral Optoacoustic Tomography (MSOT) technology for clinical diagnostics. The company focuses on optoacoustic imaging systems designed to detect disease biomarkers related to inflammation, fibrosis, and cancer. Their technology translates MSOT from research settings into routine clinical use, with plans to develop clinical MSOT devices and obtain regulatory approvals in Europe and the US.

Differentiator

Problem solved

Functional benefit

Products and services

  • MSOT (Multispectral Optoacoustic Tomography) Technology Proprietary optoacoustic imaging technology that enables non-invasive visualization and quantification of functional, chemical and morphological tissue parameters by detecting disease biomarkers related to inflammation, fibrosis, and cancer through light absorption and ultrasound detection.
  • Clinical MSOT Device (in development) A clinical-grade MSOT imaging device intended for hospital and clinical use, designed to detect tumor vascularization through hemoglobin concentration measurements and translate optoacoustic imaging into routine clinical diagnostics.

Quantifiable outcome

  • Non-invasive, radiation-free diagnostic imaging alternative to traditional mammography

Companies that use iThera Medical

Customer profile

Segments1 record

Ideal customer profiles1 record

iThera Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

iThera Medical partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

iThera Medical competitors and assessment

Company assessment

Direct peers

  • Seno Medical Instruments: Seno Medical develops the Imagio optoacoustic breast imaging system, the most direct US-based competitor to iThera's MSOT breast imaging application. Both target radiation-free, functional imaging of breast tumors using optoacoustic/photoacoustic principles.
  • FUJIFILM VisualSonics: VisualSonics (owned by FUJIFILM) offers Vevo preclinical photoacoustic and high-frequency ultrasound imaging systems. It is the leading commercial supplier of optoacoustic imaging to the preclinical research market that iThera also serves with its MSOT technology.
  • ENDRA Life Sciences: ENDRA develops the TAEUS thermoacoustic/photoacoustic platform for tissue characterization, including fatty liver disease and other clinical applications. It overlaps directly with iThera on photoacoustic imaging modality and clinical translation strategy.
  • TomoWave Laboratories: TomoWave develops preclinical and research-grade optoacoustic/photoacoustic imaging systems, including the LOIS-3D small-animal imager. It is one of the closest technical peers to iThera in the multispectral optoacoustic tomography category.

Emerging players

  • PhotoSound Technologies: PhotoSound Technologies supplies optoacoustic imaging subsystems, probes, and components used in preclinical and clinical research. It overlaps with iThera as a supplier/adjacent technology provider in the optoacoustic ecosystem.

Broad incumbents

  • Hologic: Hologic is the dominant supplier of mammography and breast biopsy systems (e.g., 3Dimensions, Genius AI). As the incumbent in breast imaging, it is the most relevant established competitor iThera's MSOT breast application must displace or complement.
  • Siemens Healthineers: Siemens Healthineers offers a broad portfolio of imaging modalities (MRI, CT, ultrasound, mammography) with global sales, clinical evidence, and reimbursement infrastructure. It is the type of incumbent iThera would compete with or partner alongside in the clinical imaging market.
  • GE HealthCare: GE HealthCare is a global leader in diagnostic imaging including mammography, ultrasound, and molecular imaging. It represents both a potential competitor and a strategic channel partner for clinical optoacoustic imaging adoption.
  • Canon Medical Systems: Canon Medical Systems offers a full suite of diagnostic imaging equipment including ultrasound, CT, MRI and mammography. Its breadth and installed-base reach are comparable to other large incumbents that could integrate or compete with optoacoustic imaging.
  • Philips Healthcare: Philips Healthcare provides diagnostic imaging, ultrasound, and image-guided therapy solutions globally. Like other broad incumbents, it sets the competitive benchmark iThera's MSOT must meet on workflow integration, evidence, and reimbursement.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat2 records

Key risks2 records

Key highlights6 records

Customer concentration

iThera Medical social profiles

Digital presence

iThera Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

iThera Medical leadership team

Management profile

Number of profiles

Profiles2 records

iThera Medical funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

iThera Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iThera Medical

What does iThera Medical do?

iThera Medical develops proprietary Multispectral Optoacoustic Tomography (MSOT) technology that combines optical excitation with ultrasound detection to deliver non-invasive, high-resolution diagnostic imaging. The company is translating its MSOT platform from research into clinical applications for detecting disease biomarkers related to inflammation, fibrosis, and cancer, and is developing a clinical MSOT device targeting regulatory approvals in Europe and the United States.

Is iThera Medical a public or private company?

iThera Medical is a private company. It is classified as venture growth investor backed and is currently operating.

When was iThera Medical founded?

iThera Medical was founded in 2010. It employs 11 to 50 people.

Where is iThera Medical based?

iThera Medical is headquartered in München, Germany, in the Europe region.

How does iThera Medical make money?

One revenue line is on record: medical Device Sales (Planned).

Who are iThera Medical's main competitors?

Direct peers on record are Seno Medical Instruments, FUJIFILM VisualSonics, ENDRA Life Sciences and TomoWave Laboratories. PhotoSound Technologies is listed as an emerging player. Broad incumbents are Hologic, Siemens Healthineers, GE HealthCare, Canon Medical Systems and Philips Healthcare.

Does iThera Medical have an API?

No public API is recorded for iThera Medical.

What industry is iThera Medical in?

iThera Medical's product category is Medical Imaging Equipment. Its primary akta.pro industry code is HLAHABAF, Mammography & Breast Imaging Systems, with a secondary code of HLAHABAD, Ultrasound & Echography Systems. Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MedicalstartupsTop 11 Ultrasound startups 2025This article presents a curated list of the top 11 ultrasound startups for 2025, highlighting companies developing mobile devices, advanced transducers, and AI-based image analysis platforms. It provides specific funding amounts and country origins for each entity, such as Exo ($337M in the USA) and Neural Analytics ($73.7M in the USA). The report covers a global range of innovators including Encord (UK), iThera Medical (Germany), and Nabz Ava (Iran).FinSMEsiThera Medical Closes €13M FinancingiThera Medical, a Munich-based medical device company, has closed a €13 million funding round led by TRUMPF Venture with participation from EIC Fund and other existing investors. The company plans to utilize the capital to develop an MSOT device for routine clinical use and to secure regulatory approvals in Europe and the United States.StartbaseIthera Medical raises 13 million eurosIthera Medical has closed its Series D financing round, raising a total of 13 million euros led by Trumpf Venture with participation from existing investors like Bayern Kapital. The company intends to use the capital to transition its MSOT imaging technology from the study phase to market maturity, aiming for regulatory approval in Europe and the USA.PrwebiThera Medical closes €13 Million financing to fund translation of their optoacoustic imaging technology into routine clinical useiThera Medical closed a €13 million financing round led by TRUMPF Venture and the EIC Fund to commercialize its Multispectral Optoacoustic Tomography (MSOT) technology for routine clinical use. The proceeds will fund the development of next-generation devices, secure regulatory approvals in Europe and the United States, and expand clinical evidence. This investment supports the company's transition from research tools to diagnostic assets aimed at treating diseases such as cancer and cardiovascular conditions.PrwebiThera Medical awarded major European grant to translate its optoacoustic imaging technology from research to routine clinical useMedical device company iThera Medical secured funding from the European Commission's EIC Accelerator program for its FRONTIER project, which aims to translate optoacoustic imaging technology into routine clinical use. The grant includes €2.5 million in funding and up to €15 million in equity to support the development of multispectral optoacoustic tomography (MSOT) for diagnostic applications.